Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple MyelomaLuciano J. Costa, Parameswaran Hari, Saurabh Chhabra et al.|Clinical Lymphoma Myeloma & Leukemia|2021Cited by 45
Cilta-cel versus conventional treatment in patients with relapse/refractory multiple myeloma.Luciano J. Costa, Parameswaran Hari, Yi Lin et al.|Journal of Clinical Oncology|2021Cited by 10